First-Episode Psychosis in a Young Man With Methamphetamine Use
A 23-year-old male engineering student is brought to the psychiatric emergency unit by his father. Over the past 7 months he has withdrawn from friends, abandoned his thesis, and spoken in tangential, at times incoherent sentences. For 3 weeks he has been convinced that neighbors are transmitting messages through his mobile phone, and he hears two voices in Persian commenting on his actions. He used methamphetamine 2-3 times weekly for about 8 months and cannabis occasionally; a urine test today is positive for methamphetamine. Importantly, an earlier 6-week period of abstinence produced no change in his withdrawal or odd speech. There is no prior psychiatric contact; his paternal grandfather had a chronic psychotic illness. He is afebrile and alert, with BMI 31 kg/m2 and fasting glucose 108 mg/dL. He denies suicidal ideation and refuses to consider that he is ill. The family asks whether the drug 'explains everything' and whether he can be treated as an outpatient.
1. How would you distinguish methamphetamine-induced psychosis from a primary schizophrenia-spectrum disorder in this patient, and why does the distinction change management?
Read the worked answer
Start with the timeline, because it carries the diagnostic weight. DSM-5 substance-induced psychotic disorder requires delusions or hallucinations developing during, or within 1 month of, intoxication or withdrawal, and it should not be diagnosed when the symptoms persist for a substantial period after cessation (conventionally more than 1 month). Here psychosis persisted through a documented 6-week abstinence, which points away from a pure stimulant effect.
Supporting a primary disorder: 7 months of prodromal withdrawal and academic decline before heavy use, a family history in the grandfather, disorganized speech, and delusions that are not simple paranoid misinterpretations of intoxication. Pointing the other way: a positive urine test and frequent use, which genuinely precipitate and worsen psychosis, and the fact that methamphetamine can produce a schizophrenia-like picture that is hard to separate cross-sectionally.
Emphasize that the diagnosis is not either/or. He can have schizophrenia plus a methamphetamine use disorder, and both need treatment. The practical difference: if the psychosis were purely substance-induced, an antipsychotic could often be tapered after weeks of abstinence; with a primary disorder he needs long-term treatment and relapse prevention, and the family must understand that the drug is a relapse factor rather than 'the cause'. That framing affects adherence and stigma. Either way, do not delay antipsychotic treatment while observing.
2. What antipsychotic would you start, what monitoring is required, and when would you consider a long-acting injectable?
Read the worked answer
Given BMI 31 and fasting glucose 108 mg/dL (prediabetes), avoid olanzapine and prefer a low-metabolic-risk agent. Aripiprazole 10-15 mg once daily is a reasonable first choice: little weight gain, minimal sedation, and good evidence in first-episode psychosis. Risperidone is an alternative, but at 4 mg it carries more prolactin elevation and extrapyramidal symptoms in a young, neuroleptic-naive man. Start low and titrate over 1-2 weeks; use a benzodiazepine only briefly for agitation.
Baseline and follow-up monitoring: weight, BMI, waist circumference, blood pressure, fasting glucose or HbA1c, lipids, ECG if there is QT risk, prolactin if symptoms suggest elevation, and a movement-disorder examination (AIMS) for tardive dyskinesia. Repeat metabolic parameters at about 3 months and then annually. Give diet and activity advice now rather than after weight gain appears.
Long-acting injectable: not during an acute, uncooperative phase, but he is a strong candidate later because of stimulant use and predictable adherence problems. After 3-6 months of documented oral tolerability, discuss a long-acting injectable (for example risperidone long-acting injection, or haloperidol decanoate where available), framing it as relapse prevention rather than coercion. Avoid polypharmacy and document the rationale for every choice.
3. What would you tell the family in the first meeting, and what outpatient structure would you set up?
Read the worked answer
The family's question is the therapeutic lever. They need a clear, non-stigmatizing explanation that methamphetamine is a powerful relapse trigger but not the sole cause, framed in a stress-vulnerability model: a biological vulnerability plus drug exposure plus stress produced the episode.
Key psychoeducation points: (1) the symptoms are real and treatable; (2) continued use sharply raises relapse and rehospitalization risk and worsens the long-term course; (3) the first 2-3 years after onset are the critical period, so continuity of treatment matters more than a few symptom-free weeks; (4) reduce expressed emotion, because both criticism and over-involvement predict relapse - coach specific behaviors such as calm limit-setting, not arguing about the delusion and neither confirming nor challenging it, and scheduled rather than constantly improvised family discussions; (5) practical adherence supports: pillbox, telephone alarms, supervised administration, help with transport to clinic.
Plan: either a brief admission or an intensive outpatient schedule with frequent contact until the delusions fade, addiction counseling in parallel, and a written relapse-warning plan (sleep loss, withdrawal, irritability). Engage the father, who is the main help-seeker, and ask about financial and social resources. Give a contact number and a follow-up appointment within 1 week.